Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | GAA | P10253 | 2/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 2/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17896079 | 0.89 | LMNA (0.35) | USP2LMNAKDM4EGAAHTT | |
| SCHEMBL17896017 | 0.88 | LMNA (0.34) | USP2LMNAKDM4EPKMALDH1A1 | |
| SCHEMBL17895978 | 0.83 | LMNA (0.34) | USP2LMNAKDM4EGAAHTT | |
| SCHEMBL17895830 | 0.80 | LMNA (0.32) | USP2LMNAKDM4EPKMALDH1A1 | |
| SCHEMBL17895905 | 0.80 | LMNA (0.34) | USP2LMNAKDM4EGAAHTT | |
| SCHEMBL17896121 | 0.79 | LMNA (0.34) | USP2LMNAKDM4EPKMALDH1A1 | |
| SCHEMBL17896034 | 0.79 | LMNA (0.35) | USP2LMNAKDM4EPKMALDH1A1 | |
| SCHEMBL17895829 | 0.79 | MAPT (0.34) | USP2LMNAKDM4EGAAHTT | |
| SCHEMBL17895780 | 0.78 | LMNA (0.34) | USP2LMNAKDM4EPKMALDH1A1 | |
| SCHEMBL17896074 | 0.77 | LMNA (0.32) | LMNAKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2016109706-A1 | FUSED POLYCYCLIC 2-PYRIDINONE ANTIBACTERIAL COMPOUNDS | PTC THERAPEUTICS, INC. (US) | 2016-07-07 | — | — | WO | claimed |
| WO-2016109706-A1 | FUSED POLYCYCLIC 2-PYRIDINONE ANTIBACTERIAL COMPOUNDS | PTC THERAPEUTICS, INC. (US) | 2016-07-07 | — | — | WO | disclosed |